June 17, 2014

Another Hepatitis C Drug to come in the Market Soon

Leave a Comment / News Updates / By ipmetrix / hepatitis C, Idenix Pharmaceuticals, IDX21437, Merck & Co, New Drugs, Olysio, Sovaldi

Hepatitis C has become one of the hottest categories in drug research as companies race to develop a combination therapy without injections and debilitating side effects. Some have had their promising candidates fail after extensive testing, due to dangerous side effects, but Gilead Sciences Inc is already raking in billions of dollars from its ground …

Another Hepatitis C Drug to come in the Market Soon Read More »

Tesla Motors to “Open Source” its patents.

Leave a Comment / Licensing & OSS, News Updates / By ipmetrix / Open Source, Tesla Motors

Tesla Motors, America’s leading Manufacturer of electric cars has taken a curious step of an \”open source\” approach for its technology patents, to encourage development of electric cars. This step was taken with an intension to attract and motivate talented employees and to accelerate the mass market advancements of electric cars for sustainable transport. Tesla …

Tesla Motors to “Open Source” its patents. Read More »

What is your IP portfolio? ipMetrix provides value-added research and strategy for all IP classes.